Top Markets
#1 Pleasing Gold Pleasing Gold +562.02%
#2 Islamic Coin Islamic Coin +154.23%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +49.57%
#5 DogBull DogBull +38.73%
#6 Nockchain Nockchain +25.73%
#7 ORDI ORDI +21.49%
#8 PondCoin PondCoin +21.01%
#9 rsERG rsERG +18.16%
#10 Monad Monad +17.83%
Coin of the day
Pleasing Gold Pleasing Gold
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Peringkat dalam Saham #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Harga Saham
$1.48
Terakhir disinkronkan: 2023-05-31
Kapitalisasi Pasar
$35.54M
Perubahan (1 hari)
-5.73%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan TCR2 Therapeutics Inc. (TCRR)

Kategori

Healthcare
Riwayat hasil dividen untuk TCR2 Therapeutics Inc. (TCRR)
Hasil dividen (TTM) dari TCR2 Therapeutics Inc. (simbol saham: TCRR) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk TCR2 Therapeutics Inc. (TCRR) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH